These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 33218057

  • 1. Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report.
    Waszczykowska A, Podgórski M, Waszczykowski M, Gerlicz-Kowalczuk Z, Jurowski P.
    Int J Mol Sci; 2020 Nov 18; 21(22):. PubMed ID: 33218057
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
    Jobim FC, Xavier NL, Uchoa DM, Cruz DB, Saciloto M, Chemello N, Schwartsmann G.
    Braz J Med Biol Res; 2009 Oct 18; 42(10):979-87. PubMed ID: 19787153
    [Abstract] [Full Text] [Related]

  • 3. Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.
    Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, Buda A, Taraboletti G, Labianca R, Belotti D, Giavazzi R.
    Eur J Cancer; 2003 Sep 18; 39(13):1948-56. PubMed ID: 12932675
    [Abstract] [Full Text] [Related]

  • 4. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
    Montagnana M, Volpe A, Lippi G, Caramaschi P, Salvagno GL, Biasi D, Bambara LM, Guidi GC.
    Clin Biochem; 2007 Aug 18; 40(12):837-42. PubMed ID: 17493602
    [Abstract] [Full Text] [Related]

  • 5. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.
    Exp Eye Res; 2002 May 18; 74(5):577-84. PubMed ID: 12076079
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
    Munaut C, Noël A, Hougrand O, Foidart JM, Boniver J, Deprez M.
    Int J Cancer; 2003 Oct 10; 106(6):848-55. PubMed ID: 12918061
    [Abstract] [Full Text] [Related]

  • 7. Imbalance between Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Promotes Invasion and Metastasis of Head and Neck Squamous Cell Carcinoma.
    Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, Popescu CR, Gheorghe DC.
    Clin Lab; 2017 Oct 01; 63(10):1613-1620. PubMed ID: 29035450
    [Abstract] [Full Text] [Related]

  • 8. Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas.
    Korompelis P, Piperi C, Adamopoulos C, Dalagiorgou G, Korkolopoulou P, Sepsa A, Antsaklis A, Papavassiliou AG.
    Clin Chem Lab Med; 2015 Aug 01; 53(9):1415-24. PubMed ID: 25470608
    [Abstract] [Full Text] [Related]

  • 9. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
    Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N, Clement B, Lagente V, Malledant Y.
    Crit Care Med; 2003 Feb 01; 31(2):536-42. PubMed ID: 12576963
    [Abstract] [Full Text] [Related]

  • 10. Coexistence of proangiogenic potential and increased MMP-9, TIMP-1, and TIMP-2 levels in the plasma of patients with critical limb ischemia.
    Wieczór R, Wieczór AM, Kulwas A, Pulkowski G, Budzyński J, Rość D.
    J Zhejiang Univ Sci B; 2003 Feb 01; 20(8):687-692. PubMed ID: 31273966
    [Abstract] [Full Text] [Related]

  • 11. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
    Erman H, Gelisgen R, Cengiz M, Tabak O, Erdenen F, Uzun H.
    Eur Rev Med Pharmacol Sci; 2016 Feb 01; 20(6):1015-22. PubMed ID: 27049251
    [Abstract] [Full Text] [Related]

  • 12. Expression of the matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in systemic lupus erythematosus patients.
    Vira HJ, Pradhan VD, Umare VD, Chaudhary AK, Rajadhyksha AG, Nadkar MY, Ghosh K, Nadkarni AH.
    Neth J Med; 2020 Sep 01; 78(5):261-268. PubMed ID: 33093251
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D, Hrynyschyn K, Pallua N.
    Plast Reconstr Surg; 2003 Oct 01; 112(5):1279-86. PubMed ID: 14504511
    [Abstract] [Full Text] [Related]

  • 14. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, Black C, Cawston TE.
    Ann Rheum Dis; 2001 Sep 01; 60(9):846-51. PubMed ID: 11502611
    [Abstract] [Full Text] [Related]

  • 15. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
    Azevedo Martins JM, Rabelo-Santos SH, do Amaral Westin MC, Zeferino LC.
    BMC Cancer; 2020 Jul 15; 20(1):660. PubMed ID: 32669083
    [Abstract] [Full Text] [Related]

  • 16. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O, Ganster M, Baumgartner I, Nieselt K, Djonov V.
    J Vasc Res; 2007 Jul 15; 44(3):202-13. PubMed ID: 17337906
    [Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinase imbalance in inguinal hernia formation.
    Antoniou GA, Tentes IK, Antoniou SA, Simopoulos C, Lazarides MK.
    J Invest Surg; 2011 Jul 15; 24(4):145-50. PubMed ID: 21675849
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinases (MMP-1, MMP-2, MMP-3 and MMP-9, and TIMP-1, TIMP-2 and TIMP-3) and markers for vascularization in functioning and non-functioning bleb capsules of glaucoma drainage implants.
    Välimäki J, Uusitalo H.
    Acta Ophthalmol; 2015 Aug 15; 93(5):450-456. PubMed ID: 25588965
    [Abstract] [Full Text] [Related]

  • 19. [Expression of matrix metalloproteinases and their inhibitors in the internal carotid artery wall in pathological tortuosity].
    Paltseva EM, Polyakova VO, Oskolkova SA, Abramyan AV, Ivanova AG, Krylova YS, Gavrilenko AV.
    Arkh Patol; 2016 Aug 15; 78(3):26-31. PubMed ID: 27296003
    [Abstract] [Full Text] [Related]

  • 20. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY, Wu YQ, Fan SQ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 15; 28(3):212-6. PubMed ID: 14653069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.